Journals / European Journal of Rheumatology / 2016 / Cilt: 3 - Sayı: 3

Severe hypocalcemia and prolonged QT interval due to denosumab in an elderly woman with rheumatoid arthritis and chronic kidney disease

Pages
144–145
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

OİWA, H., MOKUDA, S. (2022). Severe hypocalcemia and prolonged QT interval due to denosumab in an elderly woman with rheumatoid arthritis and chronic kidney disease. European Journal of Rheumatology, Cilt: 3 - Sayı: 3, 144–145. https://ajindex.com/articles/650461

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Qi WX1, Lin F, He AN, Tang LN, Shen Z, Yao Y. Incidence and risk of denosumab-related hypocalcemia in cancer patients: a systemat- ic review and pooled analysis of randomized controlled studies. Curr Med Res Opin 2013; 29: 1067-73. [CrossRef] Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, et al. Denosumab for prevention of fractures in postmenopaus- al women with osteoporosis. N Engl J Med 2009; 361: 756-65. [CrossRef] Block GA, Bone HG, Fang L, Lee E, Padhi D. A single-dose study of denosumab in patients with various degrees of renal impairment. J Bone Miner Res 2012; 27: 1471-9. [CrossRef] Dave V, Chiang CY, Booth J, Mount PF. Hy- pocalcemia post denosumab in patients with chronic kidney disease stage 4-5. Am J Nephrol 2015; 41: 129-37. [CrossRef] Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimat- ed GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982-92. [CrossRef] Cockcroft DW, Gault MH. Prediction of creati- nine clearance from serum creatinine. Neph- ron 1976; 16: 31-41. [CrossRef] 145